- US-listed companies
- GoodRx Holdings, Inc.
- Income statement
GoodRx Holdings, Inc.GDRX
Market cap
$992.93M
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 551 | 745 | 767 | 750 | 792 |
| Revenue growth (%) | - | ||||
| Cost of revenue | 30 | 47 | 65 | 67 | 48 |
| Research & development | 62 | 126 | 143 | 136 | 124 |
| Operating margin (%) | |||||
| Operating income | -276 | 13 | 2 | -27 | 66 |
| Operating expenses | 826 | 732 | 765 | 777 | 726 |
| Income before tax | -303 | -10 | -23 | -56 | 31 |
| Pretax margin (%) | -55.1 | -1.4 | -3 | -7.4 | 4 |
| Provision for income taxes | -10 | 15 | 10 | -47 | 15 |
| Effective tax rate (%) | |||||
| Net income | -294 | -25 | -33 | -9 | 16 |
| Net income margin (%) | |||||
| Earnings per share | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 |
| Diluted EPS | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 |